International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Vehicle for Oral Suspension (National Formulary 26)

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2015 - Volume 19, Number 5
View All Articles in Issue

Page(s): 413

Vehicle for Oral Suspension (National Formulary 26) Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Vehicle for Oral Suspension (National Formulary 26). Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, oral preparations, National Formulary

Related Categories: EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Vehicle for Oral Suspension (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 413
Vehicle for Oral Solution (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 411
Vehicle for Oral Solution, Sugar Free (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 412
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor Allen Loyd V Jr	May/Jun 2004 Pg. 162
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Allen Loyd V Jr	Sep/Oct 2016 Pg. 356
Oral Liquid Vehicles, Featured Excipient: Allen Loyd V Jr	Jan/Feb 2001 Pg. 65-67
Women's Oral Health: Is There a Hormonal Link? Preckshot John	Jan/Feb 2004 Pg. 10-14
Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations Visser J Carolina, ten Seldam Inge E J, van der Linden Isabella J, Hinrichs Wouter L J, Veenendaal Reinier F H, Dijkers Eli C F, Woerdenbag Herman J	May/Jun 2018 Pg. 247-251
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora	Jan/Feb 2001 Pg. 9-12
Suspension Solution, Sugar Free Allen Loyd V Jr	Jan/Feb 2023 Pg. 58-59
Nitazoxanide 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2023 Pg. 420
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students Benischek Rita	Mar/Apr 2017 Pg. 105-108
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria	Nov/Dec 2009 Pg. 532-536
Atomoxetine 4-mg/mL Oral Solution/Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 321
Sorafenib 20-mg/mL in Oil Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 420
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 416
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 505
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Return to Top